Mednet Logo

How do you transition to an anabolic agent in a patient who develops an atypical fracture while on denosumab?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Rheumatology · UC Davis
Answered on

It is not usual to suffer an atypical fracture of the femur from denosumab, however, they do occur. It is useful to start an anabolic agent, either abaloparatide or teriparatide for both augment fracture healing and to treat the osteoporosis. Both abaloparatide and teriparatide stimulate bone format...

Join for free or sign in to see the full answer